Zoe Donaldson
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pair Bond | 9 | 2024 | 14 | 5.210 |
Why?
| Arvicolinae | 13 | 2024 | 24 | 4.690 |
Why?
| Social Behavior | 16 | 2024 | 266 | 3.690 |
Why?
| Nucleus Accumbens | 4 | 2024 | 124 | 2.880 |
Why?
| Grassland | 4 | 2023 | 48 | 2.320 |
Why?
| Receptor, Serotonin, 5-HT1A | 6 | 2019 | 39 | 2.300 |
Why?
| Sexual Behavior, Animal | 5 | 2022 | 48 | 1.720 |
Why?
| Receptors, Vasopressin | 6 | 2018 | 18 | 1.670 |
Why?
| Brain | 10 | 2023 | 2378 | 1.480 |
Why?
| Oxytocin | 2 | 2021 | 45 | 1.030 |
Why?
| Optogenetics | 3 | 2021 | 95 | 0.940 |
Why?
| Mental Disorders | 4 | 2016 | 897 | 0.880 |
Why?
| Dopamine | 3 | 2024 | 236 | 0.830 |
Why?
| 5' Flanking Region | 3 | 2013 | 8 | 0.790 |
Why?
| Sex Characteristics | 3 | 2022 | 639 | 0.790 |
Why?
| Microsatellite Repeats | 3 | 2013 | 137 | 0.750 |
Why?
| Receptors, Opioid | 1 | 2021 | 19 | 0.750 |
Why?
| Neuronal Plasticity | 1 | 2022 | 209 | 0.730 |
Why?
| Animals | 30 | 2024 | 31884 | 0.720 |
Why?
| Object Attachment | 2 | 2018 | 33 | 0.680 |
Why?
| Microglia | 1 | 2021 | 202 | 0.650 |
Why?
| Software | 1 | 2023 | 538 | 0.650 |
Why?
| Neurons | 4 | 2020 | 1285 | 0.630 |
Why?
| Models, Animal | 1 | 2018 | 349 | 0.540 |
Why?
| Depressive Disorder | 1 | 2019 | 333 | 0.520 |
Why?
| Receptors, Oxytocin | 2 | 2022 | 23 | 0.510 |
Why?
| Mating Preference, Animal | 2 | 2020 | 30 | 0.510 |
Why?
| Behavior, Animal | 2 | 2019 | 462 | 0.480 |
Why?
| Biological Psychiatry | 1 | 2014 | 2 | 0.470 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2019 | 1902 | 0.460 |
Why?
| Epigenesis, Genetic | 1 | 2018 | 524 | 0.450 |
Why?
| Depression | 2 | 2019 | 1137 | 0.450 |
Why?
| Autoreceptors | 1 | 2013 | 2 | 0.450 |
Why?
| Disease Models, Animal | 4 | 2019 | 3547 | 0.410 |
Why?
| Behavior | 1 | 2013 | 91 | 0.410 |
Why?
| DNA-Binding Proteins | 4 | 2023 | 1318 | 0.390 |
Why?
| Affect | 1 | 2013 | 246 | 0.370 |
Why?
| Anxiety Disorders | 1 | 2013 | 307 | 0.360 |
Why?
| Male | 19 | 2023 | 55814 | 0.340 |
Why?
| Transcription Factors | 2 | 2018 | 1531 | 0.330 |
Why?
| Transduction, Genetic | 1 | 2009 | 113 | 0.320 |
Why?
| Transgenes | 1 | 2009 | 170 | 0.320 |
Why?
| Vasopressins | 1 | 2008 | 56 | 0.310 |
Why?
| Genetic Vectors | 1 | 2009 | 291 | 0.310 |
Why?
| Primates | 1 | 2008 | 111 | 0.290 |
Why?
| Dentate Gyrus | 2 | 2017 | 30 | 0.270 |
Why?
| Female | 15 | 2022 | 59720 | 0.260 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2018 | 94 | 0.260 |
Why?
| Mice | 8 | 2021 | 14934 | 0.250 |
Why?
| Species Specificity | 2 | 2018 | 549 | 0.240 |
Why?
| Evolution, Molecular | 1 | 2008 | 437 | 0.230 |
Why?
| Polymorphism, Genetic | 3 | 2013 | 618 | 0.230 |
Why?
| Neurobiology | 1 | 2024 | 16 | 0.230 |
Why?
| Grief | 1 | 2024 | 35 | 0.230 |
Why?
| Genomics | 2 | 2018 | 641 | 0.220 |
Why?
| Time Factors | 4 | 2024 | 6157 | 0.220 |
Why?
| Humans | 17 | 2024 | 115222 | 0.210 |
Why?
| Reward | 2 | 2022 | 212 | 0.200 |
Why?
| Wireless Technology | 1 | 2021 | 11 | 0.190 |
Why?
| Mice, Knockout | 4 | 2018 | 2586 | 0.170 |
Why?
| Integrases | 1 | 2020 | 116 | 0.170 |
Why?
| Gene Expression | 2 | 2016 | 1424 | 0.170 |
Why?
| Motivation | 1 | 2024 | 498 | 0.170 |
Why?
| Choice Behavior | 1 | 2020 | 156 | 0.160 |
Why?
| Mice, Transgenic | 3 | 2019 | 1956 | 0.160 |
Why?
| Philadelphia Chromosome | 1 | 2018 | 15 | 0.160 |
Why?
| Methyl-CpG-Binding Protein 2 | 1 | 2018 | 11 | 0.150 |
Why?
| Prefrontal Cortex | 2 | 2020 | 261 | 0.150 |
Why?
| Ethology | 1 | 2018 | 1 | 0.150 |
Why?
| Alleles | 2 | 2019 | 792 | 0.150 |
Why?
| Translocation, Genetic | 1 | 2018 | 94 | 0.150 |
Why?
| Serotonergic Neurons | 1 | 2018 | 24 | 0.150 |
Why?
| Molecular Biology | 1 | 2018 | 57 | 0.150 |
Why?
| Mice, 129 Strain | 2 | 2017 | 76 | 0.150 |
Why?
| Fear | 1 | 2020 | 292 | 0.140 |
Why?
| Ecology | 1 | 2018 | 97 | 0.140 |
Why?
| Individuality | 1 | 2018 | 146 | 0.140 |
Why?
| Genetic Predisposition to Disease | 2 | 2016 | 2109 | 0.130 |
Why?
| Memory | 1 | 2017 | 209 | 0.130 |
Why?
| Reproducibility of Results | 1 | 2023 | 2806 | 0.130 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2015 | 38 | 0.130 |
Why?
| Cytoplasmic Granules | 1 | 2015 | 82 | 0.130 |
Why?
| Fluoxetine | 1 | 2015 | 46 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 2018 | 386 | 0.120 |
Why?
| Courtship | 1 | 2014 | 11 | 0.120 |
Why?
| Avian Proteins | 1 | 2014 | 20 | 0.120 |
Why?
| Motor Activity | 1 | 2019 | 643 | 0.120 |
Why?
| Suicide, Attempted | 1 | 2017 | 314 | 0.120 |
Why?
| Fusion Proteins, bcr-abl | 1 | 2014 | 61 | 0.110 |
Why?
| Mice, Inbred CBA | 1 | 2013 | 54 | 0.110 |
Why?
| Homologous Recombination | 1 | 2013 | 20 | 0.110 |
Why?
| Benzamides | 1 | 2014 | 168 | 0.110 |
Why?
| Genetic Variation | 2 | 2008 | 876 | 0.110 |
Why?
| Estrogen Receptor alpha | 1 | 2014 | 121 | 0.110 |
Why?
| Receptors, Androgen | 1 | 2014 | 131 | 0.110 |
Why?
| Suicidal Ideation | 1 | 2017 | 397 | 0.100 |
Why?
| Alzheimer Disease | 1 | 2017 | 436 | 0.100 |
Why?
| Pan troglodytes | 1 | 2012 | 47 | 0.100 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 231 | 0.100 |
Why?
| Biomarkers, Tumor | 1 | 2018 | 1046 | 0.100 |
Why?
| Piperazines | 1 | 2014 | 313 | 0.100 |
Why?
| Rats | 1 | 2020 | 4980 | 0.100 |
Why?
| Anxiety | 1 | 2018 | 846 | 0.100 |
Why?
| Pyrimidines | 1 | 2014 | 374 | 0.090 |
Why?
| Gene Frequency | 2 | 2012 | 483 | 0.090 |
Why?
| Suicide | 1 | 2017 | 500 | 0.090 |
Why?
| Personality | 1 | 2012 | 114 | 0.090 |
Why?
| Genotype | 2 | 2014 | 1781 | 0.090 |
Why?
| Antidiuretic Hormone Receptor Antagonists | 1 | 2010 | 8 | 0.090 |
Why?
| Injections, Intraventricular | 1 | 2010 | 71 | 0.090 |
Why?
| Arginine Vasopressin | 1 | 2010 | 46 | 0.090 |
Why?
| Hormone Antagonists | 1 | 2010 | 33 | 0.090 |
Why?
| Blotting, Southern | 1 | 2009 | 68 | 0.080 |
Why?
| Mice, Inbred C57BL | 3 | 2017 | 4718 | 0.080 |
Why?
| Lentivirus | 1 | 2009 | 45 | 0.080 |
Why?
| Vasoconstrictor Agents | 1 | 2010 | 113 | 0.080 |
Why?
| Animals, Genetically Modified | 1 | 2009 | 215 | 0.080 |
Why?
| Maternal Behavior | 1 | 2008 | 69 | 0.080 |
Why?
| Green Fluorescent Proteins | 1 | 2009 | 373 | 0.070 |
Why?
| Social Perception | 1 | 2008 | 94 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 928 | 0.070 |
Why?
| Gene Expression Profiling | 1 | 2013 | 1524 | 0.070 |
Why?
| Analysis of Variance | 1 | 2010 | 1231 | 0.070 |
Why?
| Blotting, Western | 1 | 2009 | 1150 | 0.070 |
Why?
| Age Factors | 1 | 2013 | 2900 | 0.070 |
Why?
| Phenotype | 1 | 2014 | 2814 | 0.070 |
Why?
| Dopamine beta-Hydroxylase | 1 | 2005 | 12 | 0.070 |
Why?
| Disulfiram | 1 | 2005 | 13 | 0.070 |
Why?
| Quality Improvement | 1 | 2013 | 953 | 0.060 |
Why?
| Catecholamines | 1 | 2005 | 97 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2009 | 1635 | 0.060 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2004 | 10 | 0.060 |
Why?
| Juvenile Hormones | 1 | 2004 | 7 | 0.060 |
Why?
| Pinus | 1 | 2004 | 16 | 0.060 |
Why?
| Terpenes | 1 | 2004 | 21 | 0.060 |
Why?
| Pheromones | 1 | 2004 | 24 | 0.060 |
Why?
| Phylogeny | 1 | 2008 | 796 | 0.060 |
Why?
| Molecular Sequence Data | 1 | 2008 | 2797 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2014 | 1882 | 0.050 |
Why?
| Survival Rate | 2 | 2018 | 1650 | 0.050 |
Why?
| Middle Aged | 3 | 2018 | 26873 | 0.050 |
Why?
| Aged | 2 | 2018 | 19136 | 0.050 |
Why?
| Adolescent | 2 | 2018 | 17889 | 0.050 |
Why?
| Young Adult | 1 | 2016 | 10520 | 0.050 |
Why?
| Adult | 2 | 2018 | 30711 | 0.040 |
Why?
| Mutation | 1 | 2008 | 3350 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2018 | 4430 | 0.040 |
Why?
| Presenilin-1 | 1 | 2017 | 27 | 0.040 |
Why?
| Spatial Behavior | 1 | 2017 | 20 | 0.040 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2017 | 54 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2018 | 619 | 0.030 |
Why?
| Memory Disorders | 1 | 2017 | 154 | 0.030 |
Why?
| HEK293 Cells | 1 | 2018 | 590 | 0.030 |
Why?
| Risk Factors | 2 | 2018 | 8658 | 0.030 |
Why?
| Neurogenesis | 1 | 2015 | 102 | 0.030 |
Why?
| Imatinib Mesylate | 1 | 2014 | 63 | 0.030 |
Why?
| Passeriformes | 1 | 2014 | 30 | 0.030 |
Why?
| Nuclear Proteins | 1 | 2018 | 593 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1133 | 0.030 |
Why?
| Remission Induction | 1 | 2014 | 237 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2017 | 913 | 0.030 |
Why?
| Interdisciplinary Studies | 1 | 2013 | 27 | 0.030 |
Why?
| Sex Factors | 1 | 2018 | 1722 | 0.030 |
Why?
| Psychology | 1 | 2013 | 83 | 0.030 |
Why?
| Cell Line | 1 | 2018 | 2645 | 0.030 |
Why?
| Drug Industry | 1 | 2013 | 104 | 0.020 |
Why?
| Advisory Committees | 1 | 2013 | 208 | 0.020 |
Why?
| Social Determinants of Health | 1 | 2013 | 136 | 0.020 |
Why?
| Disease Progression | 1 | 2017 | 2390 | 0.020 |
Why?
| Cognition | 1 | 2017 | 982 | 0.020 |
Why?
| Health Policy | 1 | 2013 | 333 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2013 | 1082 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2018 | 2330 | 0.020 |
Why?
| Aging | 1 | 2017 | 1624 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2018 | 6358 | 0.020 |
Why?
| RNA, Messenger | 1 | 2014 | 2563 | 0.020 |
Why?
| Prognosis | 1 | 2014 | 3336 | 0.020 |
Why?
| Adrenal Cortex | 1 | 2005 | 32 | 0.020 |
Why?
| Norepinephrine | 1 | 2005 | 208 | 0.020 |
Why?
| Coleoptera | 1 | 2004 | 25 | 0.020 |
Why?
| Sesquiterpenes | 1 | 2004 | 51 | 0.010 |
Why?
| Epinephrine | 1 | 2005 | 167 | 0.010 |
Why?
| Pharmacogenetics | 1 | 2005 | 149 | 0.010 |
Why?
| Serotonin | 1 | 2005 | 296 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 753 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2005 | 1860 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2004 | 1317 | 0.010 |
Why?
|
|
Donaldson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|